[Changes in IGFBP-3 in relation to administration of rGH to deficient children]

Pediatr Med Chir. 1995 Jan-Feb;17(1):41-4.
[Article in Italian]

Abstract

Serum IGFBP3 levels were tested in 7 GHD children before the rGH therapy, at the end of the same therapy and 1, 2, 4, and 8 weeks later. The IGFBP3 concentration returned to the pre-therapy levels only 6 weeks after the end of the therapy.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Carrier Proteins / blood*
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Growth Disorders / drug therapy*
  • Growth Hormone / administration & dosage*
  • Growth Hormone / deficiency
  • Growth Inhibitors / blood*
  • Humans
  • Insulin-Like Growth Factor Binding Proteins
  • Male
  • Radioimmunoassay
  • Recombinant Proteins / administration & dosage
  • Somatomedins / analysis*
  • Time Factors

Substances

  • Carrier Proteins
  • Growth Inhibitors
  • Insulin-Like Growth Factor Binding Proteins
  • Recombinant Proteins
  • Somatomedins
  • Growth Hormone